Cardiovascular Journal of Africa: Vol 24 No 4 (May 2013) - page 2

Target the CLOT
with Confidence
protects long term against further
atherothrombotic events
Compared to the originator, Clopivas has 1
• Proven bioequivalence
• No signicant difference in % of inhibi�on
of platelet aggrega�on
• The same chemical form II
• An equivalent dissolu�on prole
• A similar purity/impurity prole
Cipla Medpro (Pty) Ltd. Reg. No. 1995/004182/07 Rosen Heights, Pasita Street, Rosen Park, Bellville, 7530. Tel (021) 943 4200, Fax (021) 914 4699
Email:medicalpa@ciplamedpro.co.za, Website:www.cipla.co.za
S3 Reg. No. 41/8.2/0766
REFERENCE:
1. Data on file.